Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095302022> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2095302022 endingPage "Fa62" @default.
- W2095302022 startingPage "Fa62" @default.
- W2095302022 abstract "<h3>Background</h3> Drugs used by rheumatologists to control disease are not all safe during conception, pregnancy and lactation.1 No clear guidelines exist on the use of rheumatology drugs during pregnancy. We compare the current practice among rheumatologists and obstetricians across the UK. <h3>Methods</h3> A questionnaire was devised to address individual drugs used during pre-conception, pregnancy and lactation. Members of the British Society of Rheumatology and the British Maternal Fetal Medicine Society were contacted via an electronic link. The results were analysed by the online survey software and Fisher exact testing. <h3>Results</h3> Our results show differences between rheumatologists and obstetricians respectively. 500 members of each society were emailed. There were 102 (20%) versus 33 (7%) respondents. With regard to medication, we asked in relation to advice given before conception; hydroxychloroquine 80% versus 61% continue, 19% versus 15% discontinue (p=1.0); sulphasalazine 59% versus 70% continue, 41% versus 6% discontinue (p=0.002); azathioprine 62% versus 58% continue, 36% versus 21% discontinue (p=0.37); methotrexate 0% versus 3% continue, 100% versus 76% discontinue (p=0.2); leflunomide 0% versus 0% continue, 98% versus 42% discontinue (p=1.0); Anti-tumour necrosis factor therapy 7% versus 15% continue, 54% versus 54% discontinue (p=0.05); rituximab 2% versus 12% continue, 95% versus 52% (p=0.01) would discontinue prior to conception. <h3>Conclusion</h3> This survey is the first of its nature among rheumatologists and obstetricians. Most would give advice to continue with sulphasalazine, azathioprine and stop methotrexate and leflunomide. We observed no uniform practice and therefore recommend guidelines." @default.
- W2095302022 created "2016-06-24" @default.
- W2095302022 creator A5001616337 @default.
- W2095302022 creator A5007522134 @default.
- W2095302022 creator A5059069254 @default.
- W2095302022 creator A5086483854 @default.
- W2095302022 date "2011-06-01" @default.
- W2095302022 modified "2023-09-26" @default.
- W2095302022 title "A national survey on the use of rheumatology drugs during pregnancy" @default.
- W2095302022 doi "https://doi.org/10.1136/adc.2011.300161.28" @default.
- W2095302022 hasPublicationYear "2011" @default.
- W2095302022 type Work @default.
- W2095302022 sameAs 2095302022 @default.
- W2095302022 citedByCount "0" @default.
- W2095302022 crossrefType "journal-article" @default.
- W2095302022 hasAuthorship W2095302022A5001616337 @default.
- W2095302022 hasAuthorship W2095302022A5007522134 @default.
- W2095302022 hasAuthorship W2095302022A5059069254 @default.
- W2095302022 hasAuthorship W2095302022A5086483854 @default.
- W2095302022 hasConcept C126322002 @default.
- W2095302022 hasConcept C187212893 @default.
- W2095302022 hasConcept C198451711 @default.
- W2095302022 hasConcept C2775905006 @default.
- W2095302022 hasConcept C2776760755 @default.
- W2095302022 hasConcept C2778715236 @default.
- W2095302022 hasConcept C2779123688 @default.
- W2095302022 hasConcept C2779134260 @default.
- W2095302022 hasConcept C2779234561 @default.
- W2095302022 hasConcept C2779338263 @default.
- W2095302022 hasConcept C2780653079 @default.
- W2095302022 hasConcept C2781059491 @default.
- W2095302022 hasConcept C3008058167 @default.
- W2095302022 hasConcept C512399662 @default.
- W2095302022 hasConcept C524204448 @default.
- W2095302022 hasConcept C54355233 @default.
- W2095302022 hasConcept C71924100 @default.
- W2095302022 hasConcept C86803240 @default.
- W2095302022 hasConceptScore W2095302022C126322002 @default.
- W2095302022 hasConceptScore W2095302022C187212893 @default.
- W2095302022 hasConceptScore W2095302022C198451711 @default.
- W2095302022 hasConceptScore W2095302022C2775905006 @default.
- W2095302022 hasConceptScore W2095302022C2776760755 @default.
- W2095302022 hasConceptScore W2095302022C2778715236 @default.
- W2095302022 hasConceptScore W2095302022C2779123688 @default.
- W2095302022 hasConceptScore W2095302022C2779134260 @default.
- W2095302022 hasConceptScore W2095302022C2779234561 @default.
- W2095302022 hasConceptScore W2095302022C2779338263 @default.
- W2095302022 hasConceptScore W2095302022C2780653079 @default.
- W2095302022 hasConceptScore W2095302022C2781059491 @default.
- W2095302022 hasConceptScore W2095302022C3008058167 @default.
- W2095302022 hasConceptScore W2095302022C512399662 @default.
- W2095302022 hasConceptScore W2095302022C524204448 @default.
- W2095302022 hasConceptScore W2095302022C54355233 @default.
- W2095302022 hasConceptScore W2095302022C71924100 @default.
- W2095302022 hasConceptScore W2095302022C86803240 @default.
- W2095302022 hasIssue "Supplement 1" @default.
- W2095302022 hasLocation W20953020221 @default.
- W2095302022 hasOpenAccess W2095302022 @default.
- W2095302022 hasPrimaryLocation W20953020221 @default.
- W2095302022 hasRelatedWork W2030171189 @default.
- W2095302022 hasRelatedWork W2032024799 @default.
- W2095302022 hasRelatedWork W2044163764 @default.
- W2095302022 hasRelatedWork W2046005537 @default.
- W2095302022 hasRelatedWork W2115747799 @default.
- W2095302022 hasRelatedWork W2172752829 @default.
- W2095302022 hasRelatedWork W2416419562 @default.
- W2095302022 hasRelatedWork W2524966882 @default.
- W2095302022 hasRelatedWork W4283713144 @default.
- W2095302022 hasRelatedWork W25897310 @default.
- W2095302022 hasVolume "96" @default.
- W2095302022 isParatext "false" @default.
- W2095302022 isRetracted "false" @default.
- W2095302022 magId "2095302022" @default.
- W2095302022 workType "article" @default.